Peptides are available for research purposes only. Please review and adhere to our Terms and Conditions before ordering.CJC-1295 with DAC — CJC-1295 with drug-affinity complex (DAC) is a long-acting growth-hormone-releasing hormone (GHRH) analog that has been engineered for sustained circulation by reversible binding to serum albumin. Preclinical and mechanistic work demonstrates that sustained GHRH receptor stimulation can enhance pulsatile somatotroph activity and increase downstream IGF signaling in animal models and cell systems; the DAC modification prolongs peptide half-life and alters pharmacokinetics relative to short-lived GHRH analogs. Experimental research focuses on endocrine pharmacodynamics, receptor interactions, and tissue responses to prolonged GHRH receptor engagement rather than direct anabolic claims; interpretation of preclinical data emphasizes physiological complexity and the need for further mechanistic studies.

Peptides are available for research purposes only.
Please review and adhere to our Terms and Conditions before ordering.